| Target Price | CHF678.30 |
| Price | CHF537.80 |
| Potential | 26.13% |
| Number of Estimates | 26 |
| 26 Analysts have issued a price target Lonza 2027 . The average Lonza target price is CHF678.30. This is 26.13% higher than the current stock price. The highest price target is CHF855.75 59.12% , the lowest is CHF486.83 9.48% . | |
| A rating was issued by 30 analysts: 26 Analysts recommend Lonza to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Lonza stock has an average upside potential 2027 of 26.13% . Most analysts recommend the Lonza stock at Purchase. |
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion CHF | 6.57 | 7.72 |
| 2.13% | 17.42% | |
| EBITDA Margin | 19.68% | 29.12% |
| 9.63% | 47.94% | |
| Net Margin | 9.67% | 14.93% |
| 0.64% | 54.32% |
26 Analysts have issued a sales forecast Lonza 2025 . The average Lonza sales estimate is CHF7.7b . This is 8.83% higher than the revenue of the last 12 months(TTM). The highest sales forecast is CHF8.2b 15.42% , the lowest is CHF7.3b 2.78% .
This results in the following potential growth metrics:
| 2024 | CHF6.6b | 2.13% |
|---|---|---|
| 2025 | CHF7.7b | 17.42% |
| 2026 | CHF8.5b | 9.56% |
| 2027 | CHF9.5b | 11.87% |
| 2028 | CHF10.6b | 11.95% |
| 2029 | CHF11.9b | 12.42% |
| 2030 | CHF13.4b | 12.50% |
| 2031 | CHF14.9b | 11.44% |
| 2032 | CHF16.6b | 11.06% |
25 Lonza Analysts have issued a net profit forecast 2025. The average Lonza net profit estimate is CHF1.2b . This is 57.17% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is CHF1.4b 86.14% , the lowest is CHF901m 22.97% .
This results in the following potential growth metrics and future Net Margins:
| 2024 | CHF636m | 2.75% |
|---|---|---|
| 2025 | CHF1.2b | 81.15% |
| 2026 | CHF1.4b | 17.94% |
| 2027 | CHF1.6b | 19.17% |
| 2028 | CHF1.9b | 20.38% |
| 2029 | CHF2.3b | 15.48% |
| 2030 | CHF2.8b | 23.55% |
| 2024 | 9.67% | 0.64% |
|---|---|---|
| 2025 | 14.93% | 54.32% |
| 2026 | 16.07% | 7.64% |
| 2027 | 17.12% | 6.53% |
| 2028 | 18.40% | 7.48% |
| 2029 | 18.90% | 2.72% |
| 2030 | 20.76% | 9.84% |
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share CHF | 8.92 | 16.78 |
| 0.45% | 88.12% | |
| P/E | 32.04 | |
| EV/Sales | 5.24 |
25 Analysts have issued a Lonza forecast for earnings per share. The average Lonza EPS is CHF16.78 . This is 60.73% higher than earnings per share in the financial year 2024. The highest EPS forecast is CHF19.88 90.42% , the lowest is CHF13.13 25.77% .
This results in the following potential growth metrics and future valuations:
| 2024 | CHF8.92 | 0.45% |
|---|---|---|
| 2025 | CHF16.78 | 88.12% |
| 2026 | CHF19.80 | 18.00% |
| 2027 | CHF23.59 | 19.14% |
| 2028 | CHF28.40 | 20.39% |
| 2029 | CHF32.80 | 15.49% |
| 2030 | CHF40.52 | 23.54% |
| Current | 51.51 | 23.21% |
|---|---|---|
| 2025 | 32.04 | 37.80% |
| 2026 | 27.17 | 15.20% |
| 2027 | 22.80 | 16.08% |
| 2028 | 18.94 | 16.93% |
| 2029 | 16.40 | 13.41% |
| 2030 | 13.27 | 19.09% |
Based on analysts' sales estimates for 2025, the Lonza stock is valued at an EV/Sales of 5.24 and an P/S ratio of 4.76 .
This results in the following potential growth metrics and future valuations:
| Current | 5.70 | 6.40% |
|---|---|---|
| 2025 | 5.24 | 8.06% |
| 2026 | 4.78 | 8.73% |
| 2027 | 4.28 | 10.61% |
| 2028 | 3.82 | 10.68% |
| 2029 | 3.40 | 11.05% |
| 2030 | 3.02 | 11.12% |
| 2031 | 2.71 | 10.26% |
| 2032 | 2.44 | 9.96% |
| Current | 5.18 | 11.03% |
|---|---|---|
| 2025 | 4.76 | 8.11% |
| 2026 | 4.35 | 8.73% |
| 2027 | 3.88 | 10.61% |
| 2028 | 3.47 | 10.68% |
| 2029 | 3.09 | 11.05% |
| 2030 | 2.74 | 11.12% |
| 2031 | 2.46 | 10.26% |
| 2032 | 2.22 | 9.96% |
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HSBC GLOBAL INVESTMENT RESEARCH |
Buy
➜
Buy
|
Unchanged | Nov 25 2025 |
| ROTHSCHILD & CO REDBURN |
Buy
➜
Buy
|
Unchanged | Oct 27 2025 |
| STIFEL EUROPE |
Buy
➜
Buy
|
Unchanged | Oct 23 2025 |
| JEFFERIES |
Buy
➜
Buy
|
Unchanged | Oct 23 2025 |
| ODDO BHF |
Buy
➜
Buy
|
Unchanged | Oct 23 2025 |
| KEYBANC CAPITAL MARKETS INC. |
Overweight
➜
Overweight
|
Unchanged | Oct 23 2025 |
| HSBC GLOBAL INVESTMENT RESEARCH |
Buy
➜
Buy
|
Unchanged | Aug 25 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
HSBC GLOBAL INVESTMENT RESEARCH:
Buy
➜
Buy
|
Nov 25 2025 |
|
Unchanged
ROTHSCHILD & CO REDBURN:
Buy
➜
Buy
|
Oct 27 2025 |
|
Unchanged
STIFEL EUROPE:
Buy
➜
Buy
|
Oct 23 2025 |
|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Oct 23 2025 |
|
Unchanged
ODDO BHF:
Buy
➜
Buy
|
Oct 23 2025 |
|
Unchanged
KEYBANC CAPITAL MARKETS INC.:
Overweight
➜
Overweight
|
Oct 23 2025 |
|
Unchanged
HSBC GLOBAL INVESTMENT RESEARCH:
Buy
➜
Buy
|
Aug 25 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


